Submissions by aaavl2821

Not Approved Until It’s Approved

Building longevity startups with Laura Deming, founder of Longevity Fund [video]

Interview with Max Altman, co-founder of Apollo [video]

IP strategy for biotech startups [video]

Teladoc Health reaches agreement to buy Livongo in a $18.5B deal

Facing closure, Mountain View's Red Rock Coffee asks for community support

Anatomy of a top VC: 397% IRRs and 17-IPO funds

AstraZeneca confirms Russia vaccine deal days after Covid-19 hacking accusations

Why do biotech VCs prefer older CEOs? (2019)

Young vs. “Experienced” Biotech Founders

Coming up with ideas for biotech startups [video]

A non-scientist's summary of a synbio paper

Are biotech startups 5x better at R&D than big pharma?

Valuing biotech companies: gene therapy case study

Predictions for the world of January 1, 2020

How an unemployed 29 year old created the biotech industry

Data dredging or a $50B drug: an intro to interpreting clinical data

Two patients die in now-halted study of Audentes gene therapy

Open Targets Platform

Did Human Evolution Include a Semi-Aquatic Phase?

Human challenge studies to accelerate coronavirus vaccine licensure

Biotech VC Bob Nelsen called it right on the coronavirus

Strategic Planning in Biotech During a Pandemic Crisis

First hydroxychloroquine randomized controlled trial: results disappointing